Featured

September 3, 2019

Carisma to Present at Focus Day During the CAR-TCR Summit 2019

Michael Klichinsky, co-founder and VP of Discovery, to discuss why Carisma’s CAR Macrophages are tailor-made for solid tumor immunotherapy on Friday, September 13 at 12, noon, at the Seaport World Trade Center in Boston. For meeting details, see here.

Read More

News

June 3, 2019

Carisma Therapeutics Names Dr. Robert Petit as Chief Scientific Officer

Carisma Therapeutics is excited to welcome Robert Petit, PhD as its Chief Scientific Officer. Dr. Petit is an accomplished immuno-oncology scientist, innovator and drug developer, and a C-level executive with 25 years of experience in building and leading scientific, translational, and clinical development teams in public and private companies. View press release here.

Read More
May 9, 2019

Michael Klichinsky, VP of Discovery Research, Presents at the CAR-T and the Rise of Cellicon Valley Conference

Carisma’s Michael Klichinsky, VP of Discovery Research, joins leaders in cell therapy to present at the CAR-T and the Rise of Cellicon Valley conference to be held May 9-10, 2019 at the University of Pennsylvania (Penn). The forum is presented by Penn’s Abramson Cancer Center, the Children’s Hospital of Philadelphia and Penn’s Center for Cellular […]

Read More